2BB score and signals
Rhythm Pharmaceuticals, Inc.’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 52 | Moderate |
| Momentum | 30 | Weakening |
| Financial strength | 37 | Weak |
| Quality | 100 | Very Strong |
| Risk | 40 | Low |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | Nov 2008 |
| Employees | 414 |
| 52-week range | $74.51 – $122.20 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.7302 | — | $99.86M |
| 2026-11-02 | — | -0.7445 | — | $85.58M |
| 2026-08-04 | -0.73 | -0.8376 | $71.26M | $68.62M |
| 2026-05-05 | -0.83 | -0.8697 | $60.11M | $56.89M |
Related companies